Casey Allison Rimland

Casey Allison Rimland

Auto-generated profile, based on publicly available information

Casey Allison Rimland

Medical Scientist Training Program, University of North Carolina at Chapel Hill (UNC), Chapel Hill, NC, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2017 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
FSFotios Sampaziotis
Fotios Sampaziotis
AJAlexander W Justin
Alexander W Justin
OTOlivia C Tysoe
Olivia C Tysoe
SSStephen Sawiak
Stephen Sawiak
EGEdmund M Godfrey
Edmund M Godfrey
LVLudovic Vallier
Ludovic Vallier

29 March 2020 in Hepatology
Verified
Journal Article
Open access
PDF file
CRCasey A. Rimland
Casey A. Rimland
STSamantha G. Tilson
Samantha G. Tilson
CMCarola M. Morell
Carola M. Morell
RTRute A. Tomaz
Rute A. Tomaz
WLWei‐Yu Lu
Wei‐Yu Lu
LVLudovic Vallier
Ludovic Vallier
Background and Aims: Organoids provide a powerful system to study epithelia in vitro. Recently, this approach was applied successfully to the biliary tree, a series of ductular tissues responsible for the drainage of bile and pancreatic secretions. More precisely, organoids have been derived from ductal tissue located outside (extrahepatic bile ducts; EHBDs) or inside the liver (intrahepatic bile ducts; IHBDs). These organoids share many characteristics, including expression of cholangiocyte markers such as keratin (KRT) 19. However, the relationship between these organoids and their tissues of origin, and to each other, is largely unknown. Approach and Results: Organoids were derived from human gallbladder, common bile duct, pancreatic duct, and IHBDs using culture conditions promoting WNT signaling. The resulting IHBD and EHBD organoids expressed stem/progenitor markers leucine‐rich repeat–containing G‐protein‐coupled receptor 5/prominin 1 and ductal markers KRT19/KRT7. However, RNA sequencing revealed that organoids conserve only a limited number of regional‐specific markers corresponding to their location of origin. Of particular interest, down‐regulation of biliary markers and up‐regulation of cell‐cycle genes were observed in organoids. IHBD and EHBD organoids diverged in their response to WNT signaling, and only IHBDs were able to express a low level of hepatocyte markers under differentiation conditions. Conclusions: Taken together, our results demonstrate that differences exist not only between extrahepatic biliary organoids and their tissue of origin, but also between IHBD and EHBD organoids. This information may help to understand the tissue specificity of cholangiopathies and also to identify targets for therapeutic development.

8 July 2020 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
MFMarcela Ferrada
Marcela Ferrada
CRCasey A. Rimland
Casey A. Rimland
KQKaitlin Quinn
Kaitlin Quinn
KSKeith Sikora
Keith Sikora
JKJeff Kim
Jeff Kim
PGPeter C. Grayson
Peter C. Grayson

1 February 2020 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
KQKaitlin A. Quinn
Kaitlin A. Quinn
JRJoel S. Rosenblum
Joel S. Rosenblum
CRCasey A. Rimland
Casey A. Rimland
KGK. Bates Gribbons
K. Bates Gribbons
MAMark A. Ahlman
Mark A. Ahlman
PGPeter C. Grayson
Peter C. Grayson

1 February 2020 in Annals of the Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
DMDespina Michailidou
Despina Michailidou
JRJoel S Rosenblum
Joel S Rosenblum
CRCasey A Rimland
Casey A Rimland
JMJamie Marko
Jamie Marko
MAMark A Ahlman
Mark A Ahlman
PGPeter C Grayson
Peter C Grayson
Objective To compare the presence of head, neck and upper extremity symptoms in patients with Takayasu’s (TAK) and giant cell arteritis (GCA) and their association with vascular inflammation assessed by 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) or arterial damage assessed by magnetic resonance angiography (MRA). Methods Patients with TAK and GCA underwent clinical and imaging assessments within 24 hours, blinded to each other. Vascular inflammation was defined as arterial FDG-PET uptake greater than liver by visual assessment. Arterial damage was defined as stenosis, occlusion, or aneurysm by MRA. Clinically reported symptoms were compared with corresponding imaging findings using generalised mixed model regression. Cranial symptoms were studied in association with burden of arterial disease in the neck using ordinal regression. Results Participants with TAK (n=56) and GCA (n=54) contributed data from 270 visits. Carotidynia was reported only in patients with TAK (21%) and was associated with vascular inflammation (p<0.01) but not damage (p=0.33) in the corresponding carotid artery. Posterior headache was reported in TAK (16%) and GCA (20%) but was only associated with corresponding vertebral artery inflammation and damage in GCA (p<0.01). Arm claudication was associated with subclavian artery damage (p<0.01) and inflammation (p=0.04) in TAK and with damage in GCA (p<0.01). Patients with an increased burden of damaged neck arteries were more likely to experience positional lightheadedness (p<0.01) or a major central nervous system event (p=0.01). Conclusion The distribution of symptoms and association with imaging abnormalities differs in patients with TAK and GCA. These findings may help clinicians predict associated FDG-PET and MRA findings based on a specific clinical symptom. Clinical trial registration number NCT02257866.

2 March 2010 in Archives of Clinical Neuropsychology
Verified
Journal Article
Open access
PDF file
GDGeorge J. Demakis
George J. Demakis
CRCasey A. Rimland
Casey A. Rimland
The current study was conducted to determine (a) the demographic and injury characteristics of individuals who did not receive treatment for mild brain injury and (b) the reasons these individuals do not receive or seek treatment. In a large sample of undergraduate students initially surveyed via an on-line questionnaire (n = 1,853), 35% of those who responded to a subsequent survey acknowledged that they had experienced at least one mild traumatic brain injury (TBI) for which they were not treated. Compared with those who were treated for each TBI, those who were untreated were more likely to be men and were less likely to report persisting symptoms 3 months after the injury. There were no differences in demographics or injury characteristics (e.g., length of time unconscious) between groups. Of those with an untreated TBI, the most common reasons for not seeking treatment were that the symptoms resolved quickly and that they were neither bothersome nor disruptive. Findings are discussed in terms of research on recovery from mild TBI.